chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea, malaise, injection site tenderness.  Mom gave Motrin, which helped.  Early am 3/8/16 child reports headache and blurry vision.  Able to take PO fluids without difficulty.  Mom reports feels warm, like fever, but did not take temp.  Referred to urgent care.
1/28/2022: Strated to experience chills, shaking, severe headache, and body aches 1/29/2022: Nausea, severe low back pain, severe headache, and fatigue 1/30/2022: sever headache, neck pain, back pain, swollen and painful armpit (right arm)
chilled; sore arm; fever; fatigued; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to the company on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm), PYREXIA (fever), FATIGUE (fatigued) and CHILLS (chilled) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M2A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced MYALGIA (sore arm), PYREXIA (fever) and FATIGUE (fatigued). On 11-Feb-2021, the patient experienced CHILLS (chilled). The patient was treated with IBUPROFEN ongoing since an unknown date for Myalgia and Fever, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) ongoing since an unknown date for Myalgia and Fever, at an unspecified dose and frequency. On 10-Feb-2021, PYREXIA (fever) and FATIGUE (fatigued) had resolved. At the time of the report, MYALGIA (sore arm) and CHILLS (chilled) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patent reported that following treatment with Ibuprofen and Aleve, there was improvement in fever and sore arm, however she still had a slightly sore arm. She also reported that her chills improved after she ate something.
9 hours after receiving the shot itching began on shoulders.  24 hours after shot observed hives covering shoulders from injection site to other shoulder.  48 hours after shot entire body covered with itchy hives.  72 hours after shot, joint swelling in shoulders, hands, hips, knees and feet.  Could not walk 100 yards (normally I walk 5 miles per day)  In addition, my mouth became sore and had lesions inside one of which looked like a burst blood vessel.  My voice also became hoarse and I had to speak slowly to form words. 96 hours after shot I visited a physician and was told to take a regimen of antihistamines which controlled the itching so sleep was possible.  On 11/23/21 I again visited the doctor and was put on Prednisone, 50mg.  After 36 hours I was able to walk 3 miles. Today 11/30/21 the hives are almost gone, mouth improving but still sore.  I plan to walk today 3 miles.
Dizziness, Headache, Arthralgia, Fatigue, chills Narrative:
Pt had seizure followed by cyanosis. FOC gave rescue breaths and called 911. Pt had 3-4 apneic events in ambulance lasting less than 10 seconds. Pt admitted overnight - observation - EEG/ECG.
Pt recvd 3 doses of Engerix-B vax & found to be a non-seroconverter;
This spontaneous report as received from a pharmacist refers to a 67 year old male patient. On 09-APR-2015 the patient was vaccinated with ZOSTAVAX. The pharmacist reported that the patient returned on 10-APR-2015, complaining of unspecified "normal side effects". The pharmacist noted that this was reported in VAERS # 573468. No further information was provided. Additional information has been requested.
no additional AE's were reported; The HCP reports that a patient was administered an expired dose of ROTATEQ; This spontaneous report was received from a registered medical assistant and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 03-APR-2023, the was vaccinated with expired vaccine of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, lot #1837117, expiration date: 24-MAR-2023 (strength was not provided) administered for prophylaxis (expired product administered). No additional clarifying statements or adverse event (AE) details were provided and no additional adverse events (AE's) were reported.
Body itchy all over. Tx BENADRYL 50mg IM STAT single dose. BENADRYL 25 mg PO TID.
On 5/31/21 I got a headache and noticed blurry vision.  At approximately 11pm I noticed I was dribbling when I drank from a cup.  At 2am on 6/1 I went to the Medical Office at my work and spoke to the Nurse.  After seeing my face the Nurse determined I needed to go to the ER immediately.    I went to the ER .  After CT scan and physical test they determined I had Bell's Palsy.
Towards the end of June 2021, I started having brain fog: getting confused EASILY, can't think clearly, can't multi-task, have trouble describing/ elaborating, in conversation because I can't 'find' the words, within a normal time-frame. I told my primary care doctor July 28, 2021, during my dr. appt. He suggested I take a Home Sleep Study, (which I'm currently taking), suggesting I may not be getting quality sleep. ,
8hr after vaccine, chills, fever, vomiting for 12hr. Then respiratory symptoms (cough runny nose, sore throat) for 14 days (this is possibly from child's daycare). During this te, Intervals of hot and cold sweats for 2 weeks follow vaccination. On day 14, extreme fatigue, vomiting, diarrhea every 30 min for 12 hours.  Nausea and diarrhea continues  through day 17.  Day 18, another vomiting episode. Swollen painful lymph nodes armpit on side of injection. Heightened anxiety since vaccination (potentially from my fear of vomiting). Today is day 18.
Had nausea, fatigue, fever, sore arm, itchy throat under left ear  etc. Later buzzing sound noticed constantly, in the left ear, after May 21st. Tinnitus
Red bumps that are itchy/started getting worse/has about 20 to 30 areas that exhibit the rash; Red bumps that are itchy/started getting worse/has about 20 to 30 areas that exhibit the rash; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6205; Expiration date was not reported) on the left arm on 08Mar2021 (12:15) as a 2nd dose, single, with route of administration unspecified, for COVID-19 immunization. Medical history included ongoing diabetes mellitus from 2018; bad eye sight; ongoing vasculitis; ongoing abnormal cholesterol; ongoing essential tremor; ongoing prostatomegaly; and ongoing abnormal blood pressure. Concomitant medications included ongoing losartan; ongoing atenolol; azathioprine for vasculitis from 2017 and ongoing; hydroxychloroquine for vasculitis from 2017 and ongoing; sitagliptin (JANUVIA) for blood cholesterol abnormal from May2019 and ongoing; primidone for essential tremor from Apr2020 and ongoing; tamsulosin for prostatomegaly from May2017 and ongoing; ongoing insulin for diabetes mellitus; and ongoing atorvastatin for blood pressure abnormal. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9267; Expiration date was not reported) on 15Feb2021 (when the patient was 72 years old) (11:00) for COVID-19 immunization, and had red bumps that were itchy. On an unspecified date in 2021, after the second dose of vaccination, the patient's itchy red bumps started getting worse. Some of them seem to be going away, but he probably had about 20 to 30 areas that exhibited the rash. The rash itched "like crazy", and the patient has never had itched this bad in his entire life. A week and a half prior to reporting, the patient had started taking diphenhydramine (BENARYL), but it did not seem to make a difference. The outcome of the events was not recovered.  Information on lot/batch number was available. Additional information has been requested.
Vaccination Provider told the patient that the second dose was not available at the moment; Vaccination Provider told the patient that the second dose was not available at the moment; No Adverse Event; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (Vaccination Provider told the patient that the second dose was not available at the moment), PRODUCT AVAILABILITY ISSUE (Vaccination Provider told the patient that the second dose was not available at the moment) and NO ADVERSE EVENT (No Adverse Event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Vaccination Provider told the patient that the second dose was not available at the moment), PRODUCT AVAILABILITY ISSUE (Vaccination Provider told the patient that the second dose was not available at the moment) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (Vaccination Provider told the patient that the second dose was not available at the moment), PRODUCT AVAILABILITY ISSUE (Vaccination Provider told the patient that the second dose was not available at the moment) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for PRODUCT ADMINISTRATION INTERRUPTED (Vaccination Provider told the patient that the second dose was not available at the moment) and PRODUCT AVAILABILITY ISSUE (Vaccination Provider told the patient that the second dose was not available at the moment).    No concomitant medications were reported.   It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Patient received 1st dose on 06-Oct-2021, Vaccination Provider told the patient that the second dose was not available at the moment   No treatment medication was provided.
Headache (4 days) , Body Aches (5 days), Fatigue (8 days)
rash at edge of her face, edge of eyebrow all the way down to her cheek area; Psoriasis; itch at base of her neck/she had an itch at the base of her neck palm size on both sides; This is a spontaneous report from a contactable nurse. A 66-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration on 19Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she had a COVID-19 vaccine on Saturday morning and on Sunday (20Dec2020), she had an itch at the base of her neck palm size on both sides. Stated that the rash was on edge of her face, edge of eyebrow all way down to her cheek area. The patient took Benadryl but stated that it still bothered her. She was not sure if it was from the injection or not. Also stated that she did have psoriasis and had treatment for it. Stated that she was okay. She wanted to know if the rash was from the COVID vaccine. Stated that it was her first dose and if she had any other issues than she will call back. Outcome of the events was unknown.  Information on the Lot/batch number has been requested.
Dose given was past it's Beyond Use Date of 11/26/2021. RN followed up with patient on 11/30/2021 and patient stated she had no adverse symptoms or side effects.
that evening had 25 bumps @ site;next AM had swollen area & rash all over body;taken to MD who said was rxn to immun given DPH;
Pregnant when received 1st shot; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant when received 1st shot) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. In 2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant when received 1st shot). Rreported as Normal Pregnancy Outcome. For neonate 1, The outcome was reported as Delivered NOS. In 2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant when received 1st shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported. It was reported that a healthy baby was delivered after first shot.   This case was linked to MOD-2022-508349, MOD-2022-508339 (Patient Link).   Reporter did not allow further contact
sore throat; running nose; fatigue; chills; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), OROPHARYNGEAL PAIN (sore throat), RHINITIS (running nose), FATIGUE (fatigue) and CHILLS (chills) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     The patient's past medical history not included . relevant concomitant products usage were not reported by the reporter    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 01-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), RHINITIS (running nose), FATIGUE (fatigue) and CHILLS (chills).  At the time of the report, PAIN IN EXTREMITY (sore arm), OROPHARYNGEAL PAIN (sore throat), RHINITIS (running nose), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Rec'd flu vacc 110708; presented to ER 110808 with itchy red rash over entire body face, extrem. Started with neck, broke out with all over rash next morning.
few days it became kinda hard and firm/hematoma; severe headaches; her arm was beginning to swell/injection site swelling up; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program. This 82-year-old female consumer patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9266), dose 1 via an unspecified route of administration on 11Feb2021 as single dose for covid-19 immunization.  Medical history included allergy had a lot of trouble with allergies). The patient concomitant medications was unknown.  The Caller states that after receiving her first dose, she waited for 15 minutes to an hour and had no reaction, but later that evening about bedtime noticed her arm was beginning to swell. Caller describes it as "very, very sore" and states it bothered her for about 2-3 days. Caller reported that after that the swelling went down a little to "about the size of a walnut" and states it felt "hard to the touch, did not go around the area" and stated it looks like a hematoma to her. Caller also reported getting severe headaches despite not doing anything at the time they occur. Caller stated these headaches were "mostly during the day, sometimes in the evening" and were on either side of her head and "right on top of my head" and states they come and go. On 11Feb2021 evening the injection site was swelling up, and then after a few days it became kinda hard and firm- it was not in a red way. The clinical outcome of the event vaccination site swelling was resolving, unknown for vaccination site hematoma and not resolved for severe headaches.  No follow-up attempts are possible. No further information is expected.
I am not sure if brand I chose is same as J&J but I didn't see it listed. I have felt irritable for over 2 days. I have been aching and can hardly keep eyes open no matter how much sleep I get. Anywhere on my body I had experienced pain from past injuries have felt magnified by 100.
Was exhausted and couldn't keep my eyes open for more than four hours until Tuesday, experienced severe facial swelling and hives on neck and chest consistent with an allergic reaction begining on Satuday through Tuesday morning despite taking OTC antihistamines. Saught medical treatment Tuesday morning where I received a 6-day sterioid treatment. Hives continued through Tuesday night and swelling / skin seems to have gone back to 80% normal by Wednesday morning.
Pt c/o SOB. This rapidly progressed to increase respiration, shallow breathing and gasping for air. Hr face was red - unable to speak and a look of panic on her face. Lower LOC - Epi injection give to (L) leg lateral. Pt recovered. Alert, event X3; O2 placed on Pt. EMT given report.
possible fever; tiredness; not feeling well; redness; swelling; painful; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 97-year-old female patient who received Herpes zoster (Shingrix) (batch number F3D7H, expiry date 5th July 2021) for prophylaxis.   On 1st May 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 2nd May 2019, 1 days after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and injection site pain. On 6th May 2019, the patient experienced fever, tiredness and feeling unwell. On an unknown date, the outcome of the injection site erythema and injection site swelling were not recovered/not resolved and the outcome of the injection site pain, fever, tiredness and feeling unwell were unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site pain, fever, tiredness and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on left deltoid. The patient experienced swelling, redness and pain at the sight of injection. At the time of reporting, the swelling seems to be going down but the patient was not feeling well. The site was very red and the patient was told she might have a fever which was determined by touch and she was very tired.
Patient complaint of left side of cheek swollen on 8/28/17. Advised to see physician.
Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and NAUSEA (Nausea) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, HEADACHE (Headache) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported No treatment drug was reported
ELECTRIC PAIN IN THE BLOOD VESSELS; ELECTRIC PAIN IN THE FACE; ELECTRIC PAIN IN THE GUMS; ELECTRIC PAIN IN THE TEETH; ELECTRIC PAIN IN THE BONES; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced electric pain in the blood vessels, electric pain in the face, electric pain in the gums, electric pain in the teeth, and electric pain in the bones. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the electric pain in the blood vessels, electric pain in the face, electric pain in the gums, electric pain in the teeth and electric pain in the bones was not reported. This report was non-serious.
A report received on 25Oct02 concerning a 33 year old vaccinee and approx 15 clinic staff members (demography unk) who were administered a Fluvirin injection by inappropriate route in error in Oct02. On an unk date in Oct02, the vaccinee and approx 15 staff members were administered Fluvirin with 1/2 inch needles. The reporter suspected that the staff members may have received the vaccine via a SC and not an IM route. No adverse events were reported. The reporter has assessed the relationship of the vaccines to the event unclassifiable. Update 1 13Dec02: An update report was received received from a health care professional on 13Dec02 concerning a 38 year old female vaccine who was administered Fluvirin SC on 08Oct02. On 08Oct02, the vaccinee was inadvertently administered Fluvirin SC. The outcome of the event was unk. Ref: PJP200200657, PJP200200882, PJP200200883, PJP200200884, PJP200200885, PJP200200889.
The night I got vaccinated I started to itch all over and get small hives. I took a Benadryl and it went away. On the 6th day after the injection I got a swollen, painful lymph node in my left armpit. On the 7th day after injection I started getting a welt on my left upper arm. It was itching, hot and red. It grew quickly and I went to the ER. For the next 2 days the welts more than doubled every 8 hours when the Benadryl wore off. The mass was red, hot, itchy, slightly numb, painful and got so big it prevented my arm from having a full range of movement.
Information has been received from a medical assistant concerning an unspecified number of patients of unknown age and gender. Patients' concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On an unknown dates, the patients were vaccinated with doses of improperly stored PEDVAXHIB (dose and route not reported, lot # L051123 and expiration date 13-OCT-2018). The vaccines were exposed to 46.9F for 1 hour 15 minutes. No previous temperature excursion was reported. No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a certified medical assistant concerning a 18 year old patient with no pertinent medical history and drug/reactions/allergies who on 10-JAN-2007 was vaccinated with a first dose of Gardasil (lot# 655619/1427F) IM. Concomitant therapy included NUVARING and ORTHO EVRA. On 12-MAR-2007 the patient was vaccinated with a second dose of Gardasil (lot# 6654702/0011U). On 06-MAY-2007 the patient had a cervical smear and was reported as negative. On 13-JUL-2007 the patient was vaccinated with a third dose of Gardasil (lot# 657868/0523U). On 13-JUL-2007 the patient had a cervical smear and was positive for high risk HPV. It was unknown if any symptoms have been reported. No further information is available. Additional information has been requested.
Dizzy, light headed, tingling sensation, stomach/ nausea, cold sweats, shooting pain down right leg for 10 minutes.
I did have COVID in early January. It was over 60 days since  the 10 days following my quarantine.   I experienced, 101 fever, headache, body ache, chills, exhaustion. Symptoms lasted about 12 hours.
Vaccine was administered to a patient under 65 which this vaccine is not indicated for per package insert. Patient was counseled at the time of event and wasn't concerned at the moment. No other adverse events reported in association with this event.